GO:0046513 ceramide biosynthetic process: Sphingolipid Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046513 ceramide biosynthetic process describes the enzymatic reactions that produce ceramides, the N-acylated sphingoid bases that serve as both membrane lipids and signaling molecules.
• Ceramide synthesis occurs through de novo, sphingomyelinase, and salvage pathways, with the de novo pathway initiated by serine palmitoyltransferase (SPT) and completed by ceramide synthases (CERS1-6).
• Ceramides are not a single molecule; they comprise a family of species with distinct acyl chains and sphingoid bases that exert different biological functions.
• Ceramide-enriched membrane domains act as signaling platforms that cluster receptors and regulate cellular responses such as exosome budding and apoptosis [1,5].
• Dysregulated ceramide biosynthesis is implicated in skin barrier disorders, acute kidney injury, brain ischemia, and mitochondrial dysfunction [2,3,7].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal dissection of ceramide biosynthetic genes in human disease contexts [2,6].
Description
Ceramides are central sphingolipids that function both as structural components of cellular membranes and as bioactive signaling molecules. The Gene Ontology term GO:0046513, ceramide biosynthetic process, encompasses the chemical reactions and pathways that result in the formation of ceramides, defined as any N-acylated sphingoid. This process is fundamental to membrane biology, skin barrier function, and stress responses, and its dysregulation is linked to metabolic, renal, neurological, and dermatological disorders [2,3,7]. Researchers study ceramide biosynthesis to understand how lipid composition influences cell fate, inflammation, and tissue homeostasis [1,4]. The pathway is enzymatically complex, involving multiple ceramide synthase isoforms that generate distinct ceramide species with unique functions. Advances in CRISPR gene editing now allow precise manipulation of ceramide biosynthetic genes, enabling causal studies in human cell models [2,6]. This article integrates authoritative GO annotation with published literature to provide a research-grade overview of ceramide biosynthetic process, its genes, regulation, disease relevance, and experimental methods.
ceramide biosynthetic process At A Glance
| GO ID | GO:0046513 |
|---|---|
| GO term | ceramide biosynthetic process |
| Ontology | biological_process |
| Synonym | ceramide anabolism, ceramide biosynthesis, ceramide formation, ceramide synthesis |
| Major function | Production of N-acylated sphingoid bases for membrane structure and signaling |
| Key enzymes | Serine palmitoyltransferase (SPT), ceramide synthases (CERS1-6), dihydroceramide desaturase (DEGS1) |
| Subcellular location | Endoplasmic reticulum and mitochondria-associated membranes |
| Pathway types | De novo synthesis, sphingomyelinase pathway, salvage pathway |
What Is GO:0046513?
GO:0046513 ceramide biosynthetic process is defined as the chemical reactions and pathways resulting in the formation of ceramides, which are N-acylated sphingoid bases. This biological process includes de novo synthesis from serine and palmitoyl-CoA, sphingomyelin hydrolysis, and salvage pathways that recycle sphingoid bases. The term is distinct from ceramide catabolism and encompasses the enzymatic steps catalyzed by serine palmitoyltransferase, 3-ketodihydrosphingosine reductase, dihydroceramide desaturase, and ceramide synthases. Ceramides produced through this process vary in acyl chain length and saturation, contributing to functional diversity.
Why Is ceramide biosynthetic process Important in Cell Biology?
Ceramide biosynthetic process is essential for membrane integrity, lipid raft formation, and signal transduction [4,5]. Ceramides regulate diverse cellular processes including apoptosis, autophagy, exosome secretion, and mitochondrial homeostasis [1,6]. Dysregulated ceramide synthesis contributes to skin barrier defects, acute kidney injury, brain ischemia, and metabolic disorders [2,3,7]. Because ceramide species are structurally diverse, understanding their biosynthetic pathways is critical for developing targeted therapies. CRISPR-based models allow researchers to dissect the specific roles of ceramide synthases and related enzymes in human disease [2,6].
• Ceramides are essential structural components of the skin permeability barrier, and their synthesis is stimulated by nicotinamide.
• Ceramide-enriched membrane domains serve as platforms for receptor clustering and signaling.
• Ceramide triggers budding of exosome vesicles into multivesicular endosomes, linking lipid synthesis to intercellular communication.
• Ceramides increase mitochondrial permeabilization and mtDNA-dependent inflammation in astrocytes during brain ischemia.
• Ceramide biosynthesis is implicated in acute kidney injury through mitochondrial dysfunction and lipid accumulation.
• Dysregulated ceramide metabolism is associated with skin diseases such as atopic dermatitis and psoriasis.
• Ceramides regulate mitochondrial homeostasis and cell death pathways.
• The diversity of ceramide species underlies distinct biological functions and disease associations.
• Targeting ceramide biosynthetic enzymes is a potential therapeutic strategy for metabolic and inflammatory diseases [2,7].
• CRISPR screening of ceramide pathway genes can identify novel regulators of lipid-mediated signaling.
What Happens During ceramide biosynthetic process?
De Novo Synthesis Initiation
In simple terms: The cell starts making ceramide from scratch using serine and a fatty acid building block.
The de novo pathway begins in the endoplasmic reticulum with the condensation of serine and palmitoyl-CoA by serine palmitoyltransferase (SPT), forming 3-ketodihydrosphingosine. This rate-limiting step commits the cell to sphingolipid synthesis. The product is then reduced to dihydrosphingosine (sphinganine) by 3-ketodihydrosphingosine reductase. These initial reactions are highly regulated and respond to cellular stress and lipid availability.
Ceramide Synthase-Mediated Acylation
In simple terms: Different enzymes attach various fatty acids to the sphingoid backbone to create diverse ceramides.
Dihydrosphingosine is N-acylated by one of six ceramide synthase isoforms (CERS1-6) to form dihydroceramides. Each CERS isoform exhibits specificity for distinct acyl-CoA chain lengths, generating ceramides with different biophysical properties. For example, CERS1 preferentially uses C18:0 acyl-CoA, while CERS2 uses very long-chain fatty acids. This enzymatic diversity produces the many ceramide species observed in cells.
Desaturation to Mature Ceramides
In simple terms: A final enzymatic step introduces a double bond to convert dihydroceramide into mature ceramide.
Dihydroceramide desaturase (DEGS1) introduces a trans-4,5 double bond into the sphingoid base, converting dihydroceramide to ceramide. This desaturation step is critical for the signaling functions of ceramides, as dihydroceramides often lack the same bioactivity. DEGS1 activity influences the ratio of dihydroceramide to ceramide, which has been linked to cellular stress responses.
Sphingomyelinase and Salvage Pathways
In simple terms: Ceramide can also be generated by breaking down complex sphingolipids or recycling existing ones.
In addition to de novo synthesis, ceramides are produced by the hydrolysis of sphingomyelin via sphingomyelinases (SMases) and by the salvage pathway that recycles sphingosine. These pathways allow rapid ceramide generation in response to stimuli such as cytokines, stress, or chemotherapy. The salvage pathway re-acylates sphingosine using ceramide synthases, linking turnover of complex sphingolipids to ceramide signaling.
Ceramide Transport and Membrane Domain Formation
In simple terms: Newly made ceramide moves to other membranes and clusters into signaling platforms.
Ceramides are transported from the endoplasmic reticulum to the Golgi apparatus and plasma membrane via vesicular and non-vesicular mechanisms. At the plasma membrane, ceramides self-associate into ceramide-enriched membrane domains that serve as signaling platforms. These domains facilitate receptor clustering, exosome budding, and apoptosis signaling [1,5]. Ceramide transport is also linked to mitochondrial membranes, where ceramides promote permeabilization [3,6].
Key Genes Involved in GO:0046513 ceramide biosynthetic process
The following genes encode enzymes and regulators directly involved in ceramide biosynthetic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SPTLC1 | Subunit of serine palmitoyltransferase, catalyzes first step of de novo synthesis | Mutations cause hereditary sensory neuropathy; target for knockout studies |
| SPTLC2 | Subunit of serine palmitoyltransferase | Required for de novo ceramide synthesis; knockout models show embryonic lethality |
| KDSR | 3-ketodihydrosphingosine reductase, reduces ketone intermediate | Mutations linked to skin disorders; relevant for point mutation studies |
| CERS1 | Ceramide synthase isoform, prefers C18:0 acyl-CoA | Knockout affects brain development and ceramide species |
| CERS2 | Ceramide synthase isoform, synthesizes very long-chain ceramides | Knockout impairs skin barrier and liver function |
| CERS3 | Ceramide synthase isoform, important for skin ceramides | Mutations cause autosomal recessive congenital ichthyosis |
| CERS4 | Ceramide synthase isoform, broad acyl-CoA specificity | Overexpression alters ceramide profile in cancer cells |
| CERS5 | Ceramide synthase isoform, synthesizes C16 ceramide | Knockout affects mitochondrial function |
| CERS6 | Ceramide synthase isoform, synthesizes C16 ceramide | Linked to insulin resistance and inflammation |
| DEGS1 | Dihydroceramide desaturase, converts dihydroceramide to ceramide | Knockout accumulates dihydroceramide; relevant for point mutation studies |
| SMPD1 | Acid sphingomyelinase, hydrolyzes sphingomyelin to ceramide | Deficiency causes Niemann-Pick disease; knockout models available |
| SMPD2 | Neutral sphingomyelinase, generates ceramide in response to stress | Knockout reduces stress-induced ceramide |
| SMPD3 | Neutral sphingomyelinase, involved in bone and brain development | Mutations linked to skeletal disorders |
| ASAH1 | Acid ceramidase, degrades ceramide to sphingosine | Inhibitors increase ceramide; knockout models for salvage pathway |
| CERK | Ceramide kinase, phosphorylates ceramide to ceramide-1-phosphate | Regulates ceramide levels; knockout affects inflammatory responses |
| UGCG | Glucosylceramide synthase, converts ceramide to glucosylceramide | Knockout increases ceramide; target for cancer research |
| SGMS1 | Sphingomyelin synthase, converts ceramide to sphingomyelin | Regulates ceramide homeostasis; knockout models available |
| ACER1 | Alkaline ceramidase, hydrolyzes ceramide | Overexpression reduces ceramide; relevant for skin studies |
How Is ceramide biosynthetic process Regulated?
Ceramide biosynthetic process is regulated at multiple levels, including transcriptional control of SPT and CERS genes, post-translational modification of enzymes, and feedback inhibition by downstream sphingolipids. Cellular stress, inflammatory cytokines, and chemotherapeutic agents rapidly activate sphingomyelinases to generate ceramide. Mitochondrial ceramide accumulation is regulated by BCL-2 family proteins and contributes to permeabilization. In skin, nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids, improving the epidermal permeability barrier. The salvage pathway is regulated by sphingosine kinases and ceramidases, which balance ceramide and sphingosine-1-phosphate levels.
ceramide biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CERS3 | Autosomal recessive congenital ichthyosis | Knockout keratinocytes; point mutation knock-in |
| SMPD1 | Niemann-Pick disease | Knockout hepatocytes; overexpression of wild-type vs mutant |
| CERS6 | Brain ischemia and neuroinflammation | Astrocyte knockout; mitochondrial permeabilization assays |
| CERS5 | Acute kidney injury | Renal tubular cell knockout; ischemia-reperfusion model |
| SPTLC1 | Hereditary sensory neuropathy | Knock-in of patient mutations in iPSC-derived neurons |
Ceramide Biosynthesis in Skin Disorders
Ceramides are critical for the skin permeability barrier, and reduced ceramide levels are observed in atopic dermatitis and psoriasis. Mutations in CERS3 cause autosomal recessive congenital ichthyosis, highlighting the importance of specific ceramide species in epidermal function. Nicotinamide stimulates ceramide biosynthesis, improving barrier function in dry skin. Research models using CRISPR knockout of CERS3 or SPTLC2 in keratinocytes can elucidate disease mechanisms.
Ceramides and Acute Kidney Injury
Ceramide accumulation contributes to tubular cell death and mitochondrial dysfunction in acute kidney injury. The de novo synthesis pathway is activated in renal ischemia-reperfusion injury, and inhibition of ceramide synthases is protective in preclinical models. Knockout of CERS5 or CERS6 in renal tubular cells can dissect isoform-specific effects.
Ceramides in Brain Ischemia and Neurodegeneration
During brain ischemia, ceramides increase mitochondrial permeabilization in astrocytes, triggering mtDNA-dependent inflammation. This pathway links lipid metabolism to neuroinflammation and neuronal damage. Ceramide-enriched membrane domains also participate in exosome-mediated intercellular communication in the brain. CRISPR knockout of CERS6 or SMPD2 in astrocytes can model ischemic responses.
Ceramides and Mitochondrial Homeostasis
Ceramides regulate mitochondrial dynamics, apoptosis, and mitophagy. Excessive ceramide synthesis promotes mitochondrial outer membrane permeabilization and release of pro-apoptotic factors. The balance between CERS isoforms determines mitochondrial ceramide species and their effects on organelle function. Overexpression or knockout of CERS5 in human cell lines can clarify these mechanisms.
From ceramide biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CERS3 impair skin barrier formation? | CRISPR knockout in human keratinocytes |
| Does a specific SPTLC1 mutation alter ceramide synthesis? | Point mutation knock-in in HEK293 or iPSCs |
| Can tagged CERS6 reveal subcellular localization? | Knock-in of fluorescent tag at endogenous locus |
| Does CERS5 overexpression protect against kidney injury? | Overexpression in renal tubular cells |
| Which ceramide synthase isoforms regulate exosome budding? | Knockout of CERS2, CERS5, CERS6 in HeLa cells |
| Does nicotinamide-induced ceramide synthesis require SPT? | Knockout of SPTLC2 in keratinocytes |
How to Study the ceramide biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS lipidomics | Ceramide species concentrations | Quantify changes after CERS knockout |
| Isotope tracing | Flux through de novo synthesis | Assess SPT activity in cells |
| Fluorescent ceramide imaging | Ceramide localization and domain formation | Study membrane platforms |
| CRISPR knockout screens | Genes affecting ceramide levels | Identify novel regulators |
| Western blot | Enzyme protein expression | Validate knockout efficiency |
| Enzyme activity assay | Ceramide synthase or sphingomyelinase activity | Measure functional impact of mutations |
| Exosome isolation | Ceramide-dependent exosome budding | Study multivesicular endosome sorting |
| Mitochondrial permeability assay | Ceramide-induced permeabilization | Assess astrocyte inflammation |
Lipidomics and Mass Spectrometry
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for quantifying ceramide species with different acyl chains. This method measures the products of ceramide biosynthetic process and can distinguish de novo versus salvage contributions. Targeted lipidomics is used to assess the impact of CRISPR knockout or overexpression of CERS isoforms.
Fluorescent and Isotopic Tracing
Isotope-labeled serine or palmitoyl-CoA can trace flux through the de novo ceramide synthesis pathway. Fluorescent ceramide analogs enable live-cell imaging of ceramide trafficking and membrane domain formation. These methods are valuable for studying ceramide transport and domain dynamics.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that regulate ceramide levels or sensitivity to ceramide-induced cell death. Such screens have revealed novel regulators of mitochondrial homeostasis and lipid signaling. Bioinformatics analysis of screen hits can map pathways converging on ceramide biosynthesis.
Immunoblotting and Enzyme Activity Assays
Western blotting with isoform-specific antibodies detects CERS, SPT, and DEGS1 protein levels. In vitro enzyme activity assays using radiolabeled substrates measure ceramide synthase or sphingomyelinase activity. These assays are used to validate CRISPR models and test inhibitors.
How CRISPR Can Be Used to Study GO:0046513 ceramide biosynthetic process
Knockout
CRISPR knockout of ceramide biosynthetic genes such as CERS3, CERS5, or SPTLC2 eliminates specific enzymatic activities, revealing their contributions to ceramide species and cellular phenotypes [2,6]. Knockout models are used to study skin barrier defects, mitochondrial dysfunction, and kidney injury [2,7]. These models can be validated by lipidomics and rescue experiments.
Point Mutation
Point mutation knock-in models introduce disease-associated mutations, such as those in SPTLC1 or DEGS1, to study altered enzyme function. These models are particularly useful for hereditary sensory neuropathy and ichthyosis research [2,4]. CRISPR-mediated homology-directed repair enables precise mutation introduction in human cell lines or iPSCs.
Knock-in
Knock-in of fluorescent or affinity tags at endogenous CERS or SPT loci allows real-time tracking of enzyme localization and interactions. Tagged knock-in models help visualize ceramide synthesis sites at the endoplasmic reticulum and mitochondria-associated membranes. These models are compatible with live-cell imaging and proteomics.
Overexpression
CRISPR activation or cDNA overexpression of CERS isoforms or SPT subunits increases ceramide synthesis, enabling gain-of-function studies. Overexpression models are used to test whether increased ceramide production is sufficient to induce apoptosis, mitochondrial permeabilization, or exosome release [1,6]. These models complement knockout approaches for causal inference.
How EDITGENE Supports ceramide biosynthetic process Research
Researchers studying ceramide biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in ceramide production, membrane domain formation, or disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable such causal studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for ceramide biosynthetic process research.
Frequently Asked Questions About ceramide biosynthetic process
What is GO:0046513 ceramide biosynthetic process?
GO:0046513 is a Gene Ontology biological process term defined as the chemical reactions and pathways resulting in the formation of ceramides, which are N-acylated sphingoid bases.
What genes are involved in ceramide biosynthetic process?
Key genes include SPTLC1, SPTLC2, KDSR, CERS1-6, DEGS1, SMPD1-3, and ASAH1, which encode enzymes for de novo synthesis, sphingomyelin hydrolysis, and salvage pathways.
What are the main steps of ceramide biosynthesis?
The de novo pathway involves serine palmitoyltransferase, 3-ketodihydrosphingosine reductase, ceramide synthases, and dihydroceramide desaturase, followed by transport and membrane domain formation [4,5].
How do ceramides function in cell signaling?
Ceramides form membrane domains that cluster receptors and regulate exosome budding, apoptosis, and mitochondrial permeabilization [1,5,6].
What diseases are linked to ceramide biosynthesis?
Ceramide dysregulation is linked to skin disorders like ichthyosis, acute kidney injury, brain ischemia, and Niemann-Pick disease [2,3,7].
How can CRISPR be used to study ceramide biosynthesis?
CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models allow causal dissection of ceramide synthase and sphingomyelinase functions [2,6].
What methods measure ceramide levels?
LC-MS/MS lipidomics, isotope tracing, fluorescent imaging, and enzyme activity assays are commonly used to quantify ceramide species and pathway flux [4,5].
Which ceramide synthase isoforms exist?
Six isoforms, CERS1 through CERS6, each with distinct acyl-CoA chain length specificity, generate diverse ceramide species.
Does nicotinamide affect ceramide synthesis?
Nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids to improve the epidermal permeability barrier.
How are ceramides involved in mitochondrial function?
Ceramides increase mitochondrial permeabilization and can trigger mtDNA-dependent inflammation in astrocytes during brain ischemia [3,6].
Conclusion
Ceramide biosynthetic process (GO:0046513) is a central metabolic pathway that produces a diverse family of bioactive lipids with essential roles in membrane structure, signaling, and disease. The pathway involves de novo synthesis, sphingomyelin hydrolysis, and salvage routes, with ceramide synthases generating species-specific ceramides. Dysregulation of ceramide biosynthesis contributes to skin disorders, kidney injury, brain ischemia, and mitochondrial dysfunction [2,3,6,7]. CRISPR-based cell models enable precise manipulation of ceramide biosynthetic genes, facilitating causal research and therapeutic target discovery [2,6]. Continued investigation of this pathway will advance our understanding of lipid-mediated biology and disease.
References
- 1. Trajkovic K et al.. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes.. Science 319(5867):1244-7 PMID: 18309083
- 2. Uchida Y et al.. 2021. Ceramides in Skin Health and Disease: An Update.. Am J Clin Dermatol 22(6):853-866 PMID: 34283373
- 3. Huang FQ et al.. 2025. Ceramides increase mitochondrial permeabilization to trigger mtDNA-dependent inflammation in astrocytes during brain ischemia.. Metabolism 166:156161 PMID: 39956315
- 4. Hannun YA et al.. 2011. Many ceramides.. J Biol Chem 286(32):27855-62 PMID: 21693702
- 5. Bollinger CR et al.. 2005. Ceramide-enriched membrane domains.. Biochim Biophys Acta 1746(3):284-94 PMID: 16226325
- 6. Ding S et al.. 2024. Ceramides and mitochondrial homeostasis.. Cell Signal 117:111099 PMID: 38360249
- 7. Nicholson RJ et al.. 2022. Ceramides and Acute Kidney Injury.. Semin Nephrol 42(3):151281 PMID: 36404212
- 8. Tanno O et al.. 2000. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier.. Br J Dermatol 143(3):524-31 PMID: 10971324
